Table 1.
Summary of clinical characteristics of study participants
| GCK-MODY group (n = 8) | Type 2 diabetes group (n = 10) | P | |
|---|---|---|---|
| Age at diagnosis (years) | 34.0 ± 6.9 | 49.4 ± 7.0 | <0.001 |
| Current age (years) | 36.1 ± 6.4 | 50.2 ± 6.9 | <0.001 |
| Sex (female) | 7 (87.5%) | 5 (50%) | 0.094 |
| BMI (kg/m2) | 23.9 ± 2.6 | 26.9 ± 2.2 | 0.018 |
| HbA1c | |||
| % | 6.7 ± 0.3 | 6.9 ± 0.4 | 0.323 |
| mmol/mol | 49.6 ± 3.2 | 51.5 ± 4.4 | 0.306 |
| Fasting plasma glucose (mmol/L) | 6.8 ± 0.5 | 7.0 ± 1.1 | 0.604 |
| Diabetes duration (years) | — | 0.9 (0.6–1.4) | — |
| Metformin user | — | 7 (70%) | — |
Data are mean ± SD, median (IQR), and n (%). Group differences were compared by independent samples t test or χ2 test.